دورية أكاديمية
Pharmacogenomics for Prader-Willi syndrome: caregiver interest and planned utilization.
| العنوان: | Pharmacogenomics for Prader-Willi syndrome: caregiver interest and planned utilization. |
|---|---|
| المؤلفون: | Bar-Peled Y; Department of Clinical & Diagnostic Sciences, University of Alabama at Birmingham, AL 35294, USA., Denton JJ; Department of Clinical & Diagnostic Sciences, University of Alabama at Birmingham, AL 35294, USA., Richards JL; Department of Preventive Medicine, University of Alabama at Birmingham, AL 35294, USA.; Department of Genetics & Pediatrics, University of Alabama at Birmingham Heersink School of Medicine, AL 35294, USA., Brown D; Department of Genetics & Pediatrics, University of Alabama at Birmingham Heersink School of Medicine, AL 35294, USA., Worthey E; Department of Genetics & Pediatrics, University of Alabama at Birmingham Heersink School of Medicine, AL 35294, USA., Strong TV; Department of Genetics, University of Alabama at Birmingham Heersink School of Medicine, AL 35294, USA.; Foundation for Prader-Willi Research, Covina, CA 91723, USA. |
| المصدر: | Pharmacogenomics [Pharmacogenomics] 2024 Mar; Vol. 25 (4), pp. 207-216. Date of Electronic Publication: 2024 Mar 20. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 100897350 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8042 (Electronic) Linking ISSN: 14622416 NLM ISO Abbreviation: Pharmacogenomics Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: London : Future Medicine Ltd Original Publication: London : Ashley Publications, |
| مواضيع طبية MeSH: | Pharmacogenetics*/methods , Prader-Willi Syndrome*/drug therapy , Prader-Willi Syndrome*/genetics, Child ; Humans ; Caregivers ; Surveys and Questionnaires ; Pharmacogenomic Testing |
| مستخلص: | Aim: The study aim was to determine caregiver interest and planned utilization of pharmacogenomic (PGx) results for their child with Prader-Willi syndrome. Methods: Caregivers consented to PGx testing for their child and completed a survey before receiving results. Results: Of all caregivers (n = 48), 93.8% were highly interested in their child's upcoming PGx results. Most (97.9%) planned to share results with their child's medical providers. However, only 47.9% of caregivers were confident providers would utilize the PGx results. Conclusion: Caregivers are interested in utilizing PGx but are uncertain providers will use these results in their child's care. More information about provider comfort with PGx utilization is needed to understand how PGx education would benefit providers and ultimately patients with PGx results. |
| فهرسة مساهمة: | Keywords: Prader-Willi syndrome; caregiver; personalized medicine; perspectives; pharmacogenomic testing; pharmacogenomics |
| تواريخ الأحداث: | Date Created: 20240320 Date Completed: 20240327 Latest Revision: 20240327 |
| رمز التحديث: | 20240327 |
| DOI: | 10.2217/pgs-2023-0189 |
| PMID: | 38506331 |
| قاعدة البيانات: | MEDLINE |
PDF full text from Publisher | تدمد: | 1744-8042 |
|---|---|
| DOI: | 10.2217/pgs-2023-0189 |